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Abstract
Although the World Health Organization declared an end to the recent Zika virus (ZIKV) outbreak and its association with
adverse fetal and pediatric outcome, on November 18, 2016, the virus still remains a severe public health threat. Laboratory
experiments thus far supported the suspicions that ZIKV is a teratogenic agent. Evidence indicated that ZIKV infection
cripples the host cells’ innate immune responses, allowing productive replication and potential dissemination of the virus. In
addition, studies suggest potential transplacental passage of the virus and subsequent selective targeting of neural progenitor
cells (NPCs). Depletion of NPCs by ZIKV is associated with restricted brain growth. And while microcephaly can result from
infection at any gestational stages, the risk is greater during the first trimester. Although a number of recent studies revealed
some of specific molecular and cellular roles of ZIKV proteins of this mosquito-borne flavivirus, the mechanisms by which it
produces it suspected pathophysiological effects are not completely understood. Thus, this review highlights the cellular and
molecular evidence that implicate ZIKV in fetal and pediatric neuropathologies.
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Introduction
The Zika virus (ZIKV), a positive-stranded RNA arbovirus that belongs to the genus Flavivirus and the family
Flaviviridae, was initially identified in Uganda in 1947.1
ZIKV historically was a benign human pathological
agent,2–4 producing only mild symptoms, which included
headache, malaise, fever, cutaneous rash, arthralgia (joint
pain), and conjunctivitis in about 20% of patients and
with 80% of infections being asymptomatic.5 However,
the recent upsurge in ZIKV infection and its association
with severe fetal and congenital neurological disorders in
South America (mainly Brazil) in 2015–2016 prompted
the World Health Organization to declare the situation,
a Public Health Emergency of International Concern.6
Similar outbreaks and associated outcome occurred in
the Pacific islands (specifically the island of Yap) in
20075 and in French Polynesia in 2012–2014.7 The virus
is transmitted predominantly by infected Aedes mosquitoes (A. aegypti, A. albopictus, A. africanus, and A. luteocephalus)8 and to a lesser extent by sexual contact,9 the
prenatal route from mother to fetus,10 and through blood
transfusion.11

The epidemiological associations between ZIKV and
congenital neuropathologies have now been confirmed by
laboratory studies. The placenta and the fetal brain
appear to be 2 of the primary targets of ZIKV, leading
to fetal and congenital neurological anomalies. ZIKV
particles and proteins have been detected in human placental and fetal brain remnants.12 Experimental studies
showed that ZIKV infects, among other cells, placental
cells and neural stem cells where the virus also replicates
productively.13,14 Studies in mice suspected transplacental
ZIKV passage, resulting in restricted brain growth,15 supposedly a consequence of depletion of neural progenitor
cells (NPCs).15,16 ZIKV-induced restricted brain growth
in mice recapitulates the features of congenital ZIKVassociated microcephaly in humans.17 Other neonatal
1
Department of Biological Sciences, Bronx Community College, The City
University of New York, Bronx, New York

Corresponding Author:
Rajendra Gharbaran, Department of Biological Sciences, Bronx Community
College, The City University of New York, Bronx, NY 10453, USA.
Email: rajendra.gharbaran@bcc.cuny.edu

2
and pediatric neural disorders associated with ZIKV
infection include chorioretinopathy, sensory neural hearing loss, and epilepsy and other motor deficits. This
review discusses the putative cellular and molecular
mechanism(s) of ZIKV in human fetal and pediatric
neuropathologies.

Brief Insights Into the Molecular
Biology of ZIKV
First discovered about 70 years ago in Uganda, ZIKV
maintained a low-profile agent of human pathology.
However, the recent outbreaks of ZIKV and its associated devastating effects, in previously unsuspecting
and unaffected regions, first Oceana and subsequently
the Americas, prompted an astronomic rise in research
focus on infection by this flavivirus. The enhanced pathogenicity of ZIKV may be due to genetic changes undergone by the virus, resulting in increased aggression
characterized by increased transmissibility and infectivity,
exaggerated neurotropic potential, and greater replicative
capability. Of particular concern is the ability of the virus
to breach the placental protection and trigger permanent
fetal brain injuries.
The ZIKV virion consists of an icosahedral shell
enclosing a positive strand RNA of 10,794 kb.18–20 The
genome undergoes translation to produce a single polyprotein (of 3149 amino acids, aa), which is subsequently
cleaved to form 3 structural proteins—C (capsid) 105 aa,
PrM/M (precursor membrane) of 187 aa, the envelope
(E) of 505 aa—and 7 nonstructural proteins—NS1 (352
aa), NS2A (217aa), NS2B (139 aa), NS3 (619 aa), NS4A
(127 aa), NS4B (255 aa), and NS5 (904 aa)—by viral and
host proteases.18–20 The C protein interacts with the viral
RNA to form the nucleocaspid, and PrM is important to
prevent premature fusion of the virus with host cell membranes.21,22 The E protein, which makes up the majority
of the virion surface and which is the antigenic site for
flaviviruses, facilitates membrane attachment and
increases membrane fusion and release of viral genome
into host.23 In flaviviruses, NS1, NS3, and NS5 are large,
highly conserved proteins, whereas NS2A, NS2B, NS4A,
and NS4B proteins are small, hydrophobic proteins.24
The NS2B and NS3 proteins are important for protein
synthesis and replication of viral genetic material.18,19
NS5 protein is the most conserved nonstructural protein
among flaviviruses and functions as an RNA-directed
RNA polymerase.18,25,26
Phylogenetic studies were carried out to determine the
evolution of ZIKV.27 An African lineage and an Asian
lineage were detected.27,28 However, the contemporary
strain was more related to the Asian lineage.27,28
Human strains identified in the 2015–2016 epidemic are
closely related to the French Polynesia/2013 than the
Micronesia/2007 strain, indicating a common ancestral
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origin.27 The prM protein showed the highest percentage
variation between Asian and African subtypes, and modeling analyses indicated that some of this variability
might contribute to significant structural changes.27
Yokoyama and Starmer also identified a number of
mutations in the Asian and American ZIKV, and they
speculated that these changes are likely to inhibit cellular
antiviral activities, including immune and RNA interference pathways.29
An analysis of predicted epitopes and human antigens
indicated putative peptide sharing between ZIKV polyprotein and human proteins which are associated with
neuropathologies, including microcephaly and brain calcification.30 Such proteins include centriolar and centrosomal components that are deregulated or mutated in
microcephaly, that is, C2CD3, CASC5, CP131, GCP4,
KIF2A, STIL, and TBG.30
The genetic similarity of ZIKV to another member of
the Flaviviridae, the dengue virus (DENV), which is also
known to trigger serious pathologies in humans, may also
account for its (ZIKV) cryptic pathogenicity. ZIKV is
associated with the 4 serotypes of DENV with approximately 43% amino acid sequence similarity.31 Studies
showed that antibodies isolated from DENV patients
potently neutralize ZIKV through targeting a conformational epitope.32,33 However, it is suspected that some
ZIKV patients with a prior infection with DENV may
have a worst outcome, by a mechanism known as antibody-dependent enhancement.34 In vitro studies showed
that DENV-immune sera and DENV-specific monoclonal antibodies cross-react with ZIKV and enhance its
infectious ability via FcRs,35 although the in vivo relevance of this study remains elusive. FcRs are expressed
by a number of immune effector cells as well as by various cell types of the placenta and the central nervous
system (CNS).

Mechanism(s) of Neurocellular Invasion
The mode of cellular infection by ZIKV is a matter of
controversy. Studies showed that putative ZIKV entry
receptors include DC-SIGN (dendritic cell-specific intracellular adhesion molecule-3-grabbing nonintegrin)
receptor, heat shock protein, and tyrosine-kinase receptors TIM (TIM-1, TIM-4) and TAM (Tyro3, Axl, and
Mer)36–38 (Figure 1). TAM receptors belong to a family
of tyrosine kinase receptors which are important in the
regulation of immune responses,39 including mediating
the physiologies of microglia,40 the brain’s immune
cells. TAM receptors maintain neurogenesis in adult
brain,41 and they are important for survival, proliferation, and differentiation of neural stem cells.42
Although TAM receptors are not critical for early embryonic brain development, they are expressed by cortical
NPCs during embryogenesis,43 as well as in NPCs derived
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Figure 1. Putative receptor-mediated ZIKV infections and consequences on brain circumference. ZIKV preferentially targets
neural cells that express AXL. Upon infection, ZIKV triggers cell
death by apoptosis necrosis and autophagy and also reduces proliferation and differentiation of NPCs. Reduced NPCs resulted in
decreased head circumference typical of microcephaly.
DC-SIGN, dendritic cell-specific intracellular adhesion molecule3-grabbing nonintegrin; GAS6: growth arrest-specific protein 6;
ZIKV, Zika virus.

from pluripotent stem cells (PSCs),14 making them prime
targets for ZIKV. Of the TAM receptors, AXL, a
member of the phosphatidylserine phagocytic protein
receptors, appears to be a principal receptor exploited
by ZIKV, although the virus may use a combination of
different receptors to gain cellular entry.44 Growth arrestspecific protein 6 (GAS-6), found in blood and other
body fluids, is a natural ligand for AXL and other
TAM receptors.45 GAS-6 binds AXL at one end and
the membrane of ZIKV on the other, thereby mediating
viral entry into the host cells (Figure 1).46 Although GAS6 protein enhances the survival of oligodendrocytes and
neurons,47–50 there is no report of soluble GAS-6 in
human fetal cerebrospinal fluid (CSF). However, chronic
inflammatory conditions in the CNS are associated with
GAS-6 levels in CSF.51 In rats, GAS-6 is widely expressed
in the CNS in almost all stages of development, although
its precise role remains uncertain.52 GAS6-mediated
endocytosis of ZIKV may warrant a study that correlates
the levels of GAS-6 in body fluids and outcomes from
ZIKV infection. The expectation is that higher levels of
serum GAS-6 will result in worst prognosis in ZIKV
infection. Deregulated expression of GAS-6 and
increased serum levels of these proteins are negative prognostic factors in a number of human malignancies.53,54
Studies indicated that ZIKV may invade host cells by
TAM receptor-independent mechanism(s). Genetic ablation of AXL failed to protect NPCs and cerebral
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organoid against ZIKV infection.55 ZIKV infection of
retinal cells of Axl / knockout mice and ZIKV RNA
levels in the brains of infected Axl / mice were comparable to that of wild-type animals.56 In addition, induced
pluripotent stem cells (iPSCs) resistant to ZIKV infection
express high levels of TYRO3 messenger RNA
(mRNA).55 Results from these studies indicated that
ZIKV may also invade cells via an AXL/TYRO3-independent mechanism(s) or via other unidentified receptors.
A study in TAM (Tyro3, Axl, and Mer)-deficient mice
exposed to ZIKV showed no difference in infection when
compared to wild-type animals,57 supporting a TAMindependent tropic mechanism for this flavivirus. A
receptor-independent mechanism may involve secreted
exosomes and extracellular vesicles (ECVs). Exosomes
are membrane-bound nanosized (30–100 nm) vesicles
that appear to be secreted by almost all cell types.
Exosomes and ECVs shuttle their cargo, which may
include lipids, proteins, and nucleic acids, and other regulatory elements between host cells and target cells.
Exosomes and ECVs may modulate cellular responses
of target cells by paracrine fashion or through systemic
circulation. Studies on viruses showed that exosomes
derived from infected cells are involved in spreading
infection to adjacent cells.58–61 Finally, another receptor-independent mechanism of ZIKV infection may be
related to tunneling nanotubes (TNTs) used for intercellular communication. Studies showed that viruses can be
shuttled between neighboring cells via TNTs,62,63 thereby
assisting in immune escape although this has not been
demonstrated for flaviviruses as yet. However, it is
unclear whether ZIKV exploits similar mechanisms in
the absence of TAM receptors on target cells. It is also
possible that dissemination of ZIKV occurs by a combination of these mechanisms.

Induction and Suppression of Cellular
Defenses/Innate Immune Pathways
The pathogenicity of ZIKV may be due to its ability to
induce and subsequently suppress cellular innate immune
responses. Infection by ZIKV resulted in increased
expression of type1 IFN-stimulated genes via TLR3
activation37 and the activation of pattern recognition
receptors. IFN-stimulated gene IFITM3, a small membrane-associated IFN-inducible transmembrane protein
3, was shown to reduce the replication of flaviviruses.64
Savidis et al. showed that IFITM3 and IFITM1 inhibited
the replication of ZIKV.65 Of interest to the CNS, ZIKV
infection of human astrocytes resulted in decreased
IFITM3 levels, which is associated with increased cytoplasmic vacuoles derived from the endoplasmic reticulum
(ER), an indication of para-apoptotic cell death.66 In
addition, type III IFN, IFNl1 that are constitutively
secreted by placental trophoblasts, protected these cells
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from ZIKV infection.67 However, no antiviral activity
was detected when ZIKV-infected cells were treated
with IFNl1,67 indicating that ZIKV may antagonize
IFNl1 signaling. A study on human dendritic cells
showed that ZIKV induced strong upregulation of type
I interferon (IFN) transcript but appeared to inhibit
translation of the IFN protein, although other antiviral
proteins were upregulated.68
Other studies revealed specific roles ZIKV NS proteins
play in disrupting host immune defense, by targeting
components of the JAK/STAT pathway, presumably
depleting the host defenses. STAT1 and STAT2
are some of the transcriptional regulators of IFN
responses.69 ZIKV NS5 selectively binds to STAT2,
resulting in proteosomal degradation of this protein in
human cells but not in mice, presumably inhibiting type
I IFN signaling.70,71 In addition, NS5 expression
enhanced STAT1-STAT1 homodimers and their recruitment to IFN-g-stimulated genes such as pro-inflammatory cytokine CXCL10.72 A novel STAT2 / mouse
model showed particular vulnerability to ZIKV infection
and recapitulated viral dissemination to the CNS,
gonads, and other visceral organs, and displayed neurological symptoms73 similar to those suspected to be associated with the virus in human subjects. Intriguingly,
human STAT2 mutations, although rare, predispose
patients to multiorgan failure, including neurological
deterioration, following viral infection.74 NS1 and
NS4B proteins inhibit IFNb signaling by targeting
TBK1 (TANK-binding kinase 1 level)75 which is required
for phosphorylation of IFN regulatory factor 3 to initiate
type I IFN transcriptions.76 ZIKV NS2B-NS3 are
involved in proteosomal-directed degradation of janus
kinase I.75 Interestingly, NS1, NS4B, and NS2B-NS3
cooperate to enhance ZIKV infection by blocking IFNinduced autophagic degradation of NS2B-NS3.75 These
putative roles by ZIKV may limit neurogenesis, by interfering with growth of neural cell precursors (as described
below).

ZIKV-Induced Placental Injury and
Influence on Fetal Brain Development
The human placenta, a transient organ, provides protection against viruses by acting as a physical barrier and
offering innate and adaptive immune defenses, during in
utero development. Therefore, viral-induced changes in
placental physiologies may inflict lasting injury to the
fetal nervous system. Detection of ZIKV particles and
mRNA in the placental tissue, amniotic fluid, and corresponding fetal brain tissues12,77–79 suggests transplacental
passage by the virus. Human placentation requires invasion of the maternal decidua basalis (decidua) by trophoblasts of the blastocyst. The 2 main interfaces are the
decidua that serves as the anchoring point for the
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placenta and the intervillous space where maternal
blood is in contact with placental villi.80–82 Placental
villi are covered by a superficial multinuclear syncytiotrophoblast (STB) layer, which overlaid an inner mononuclear cytotrophoblast (CTB) layer. At the base of the
anchoring villi, proliferative CTBs differentiate into
extravillous trophoblasts, grow into the decidua, and
remodel uterine arteries to facilitate blood flow into the
intervillous space.80–82 Placental invasion by viruses may
occur via direct and contiguous infection of the cellular
layers, virion passage through a breach, or by cellmediated transport. However, it is not clear precisely
which of these mechanisms is used by ZIKV.
Nevertheless, fetal vulnerability to ZIKV during early
development is presumed to be a result of first trimester
primary trophoblast expression of AXL and other entry
receptors.83 It has been speculated that primary trophoblasts may express AXL prior to differentiation into
CTBs and STBs.83
ZIKV infection of placental chorionic villi tissues
resulted in increased expression of IFNa, IFNb, and
IFNl (but not IFNg) and the upregulation of transcripts
associated with apoptosis, cell death, and necrosis.84 Cell
death either by apoptosis or necrosis leads to the catastrophic destruction of placental architecture. Viral
destruction of developmental and placental vasculature
by ZIKV can also result in fetal brain injury.12,85
Upon infection of the placental cells, ZIKV not only
suppresses the innate and adaptive immune responses82
but may also proceed to induce the production of inflammatory cytokines and trigger the upregulation of genes
involved in apoptosis and necrosis. Analyses of human
placental tissues obtained from pregnant women showed
chronic inflammatory lesions 1 week after ZIKV infection in the first trimester, and examination of corresponding brain tissues revealed microcalcification and viral
proteins and particles in glial cells.12 Viral-induced
production of pro-inflammatory cytokines, such as
IL-1b, IL-6, and TNF-a, can alter the intra-amniotic
milieu and impact fetal brain development.
Intrauterine inflammation during pregnancy can lead to
premature births, which are associated with a number of
neurodevelopmental disorders.86 In vitro studies not
involving viral-induced secretion of pro-inflammatory
cytokines by placenta showed that IL-1b and
TNF-a decrease the proliferation of NPCs derived
from animal models.87–89 In mice, IL-1a, another proinflammatory cytokine, induces the differentiation of
astrocytes from NPCs.88 ZIKV may limit neurogenesis
by inducing NPCs differentiating into astrocyte lineage
in mice,90 although it is not clear if this is dependent
on IL-1a.
ZIKV-induced disruption of placental function can
either delay or inhibit the secretion of developmental
growth factors by this organ, potentially resulting in
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fetal brain injury. A number of studies showed that
placental-derived developmental factors are important
for neurocortical development,91–94 a principal neural
target of ZIKV. Disruption of the levels of these factors
can potentially lead to anomalies observed in infected
infants derived from viral-infected pregnancies. Viral
infection of the placenta is capable of inducing changes
in fetal brain morphology, which are associated with an
inflammatory condition in both fetal brain and fetal tissues, despite the lack of viral infection in the fetal tissue
itself.95,96
ZIKV-associated maternal inflammation may also
inhibit placental or gestational growth factors and subsequently affect neural development. Induction of maternal
inflammation alters the course of neurodevelopment,
which can influence the behavior of offsprings.97,98
Maternal inflammation resulted in deregulated production of placental-derived 5-HT, leading to neurodevelopmental defects,99 as evident by the disruption of neuronal
proliferation and axonal outgrowth.100 In addition, viralinduced inflammation of the placenta and decidua can
alter the fetal immune system, resulting in poor postnatal
immune responses to vaccines or infections that affect the
nervous system.96,101,102 ZIKV-induced placental and
maternal inflammation may be underlying mechanisms
that resulted in postnatal restricted brain growth following normal preserved head circumference at birth.
However, the precise mechanism(s) by which ZIKV
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limit placental physiology leading to restricted neural
growth is not completely understood.

Gross Neuroanatomical Changes
Imaging analyses revealed a number of gross neuroanatomical aberrations in ZIKV-associated congenital
microcephaly. Some brains showed hypoplastic cerebellar
vermis with hypoplastic cerebellar hemispheres and
brainstem hypertrophy.103 The corpus callosum, which
is important for communication between the 2 cerebral
hemispheres, appeared thin, dysgenetic, and hypoplastic
or in some cases completely absent.103 Calcification
appears widespread as well. Calcium deposits were
detected in the thalamus, basal ganglia, cortex, and periventricular regions,103 and this may be associated with
seizure and epilepsy reported for some cases of ZIKVassociated
microcephaly.104,105
Thinner
cerebral
1,14,106
cortex,
reduced gyration and loss of white and
gray matter contents, and ventriculomegaly—enlarged
brain ventricles—103,107,108 were detected (Figure 2).
Autopsy and postmortem studies on fetuses and infants
derived from ZIKV-infected pregnancies also revealed
similar neurological anomalies.109 Studies of neurospheres and brain organoids grown from human NPCs
(hNPCs) showed that ZIKV infection resulted in
restricted growth of these structures.110,111 Although the
severity of neuroanatomical malformations are greater

Figure 2. Sketches comparing a normal brain of a 5-month-old infant to that of an age-matched ZIKV-associated microcephaly brain.
Lateral view (upper row) shows reduced gyration in ZIKV-associated microcephaly brain compared to that of a normal infant. Transverse
sections (lower row) revealed calcium deposits (white spots), enlarge ventricles (asterisks), and reduced brain volume in ZIKV-associated
microcephaly brain compared to a normal brain. Gray areas are where normal brain tissue grow. Dark areas are presumed to be fluid filled
spaces, including the ventricles. ZIKV, Zika virus.
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during ZIKV infection at first trimester, ZIKV infection
at 36th week (third trimester) of pregnancy can still result
in fetal brain injury, characterized by subependymal cysts
and lenticulostriate vasculopathy in an otherwise normalsized brain.112 ZIKV-associated brain architecture may
also arise from viral-induced neuroinflammatory processes such as diffuse microglial hyperplasia and severe
astrocyte hypertrophy, macrophage, lymphocyte, and
leukocyte infiltration1,12,113–115 and release of inflammatory cytokines by infected neuronal cells.

ZIKV-Associated Molecular
Neurocytopathy
Subcellular derangement arising from ZIKV infection of
neurons may be related to changes in the expression of
genes and proteins related to the cell cycle, stress
response, cell death, intracellular structural organization,
cell differentiation, innate and adaptive immune
responses, cell proliferations, cell migration, cell adhesion, and synaptic organization.111,116–119 Notable intracellular changes resulting from ZIKV infection of
neurons include aberrant granulation pattern in the cytoplasm, irregular cell shape, partial nuclear condensation,
pyknosis or ‘‘vacuolar nuclei’’ appearance, swollen mitochondria, disorganized ER architecture, and supernumerary mitotic spindle.37,115,118,120,121 ZIKV-induced
cytoplasmic vacuolization has been demonstrated in
astrocytes, among other cell types.66 Sec61 translocondependent formation of large vacuoles from the ER and
telltale signs of paraptosis-like cell death were detected in
ZIKV-infected astrocytes.66 This effect is amplified when
IFITM protein levels are low.66
ZIKV-infected hNPCs also showed significant
reorganization of intermediate filament and microtubule
networks and remodeling of the cytoskeleton,122 perhaps
to favor viral replication. Moreover, ZIKV-infected neurons showed supernumerary foci with centriolar proteins,
supernumerary centrosomes, and impaired mitotic spindle positioning.121,123 Some of these changes are consistent with viral infection of cells and subcellular changes
associated with congenital brain malformation (eg,
microcephaly). A recent study using fission yeast for
genome-wide analysis of ZIKV proteins attributed intracellular changes to specific ZIKV proteins. All 14 structural and nonstructural ZIKV proteins and peptides were
expressed under an inducible promoter in fission yeast
and their intracellular localization and cytopathic activities subsequently determined.124 The authors found that
membrane-anchored capsid (anaC), C, prM, M, E,
NS2B, and NS4A caused elongation of cells, while cellular hypotrophy was a consequence of prM, NS2B, and
NS4A124 (Table 1).
ZIKV-induced intracellular structural disorganization
may also be related to the deregulation of genes involved
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in microcephaly. Molecular genetic analyses identified
mutations in at least 12 genes mapped to the microcephaly (MCPH) loci. Most of these genes are expressed by
NPCs where they play important roles in mitotic orientation and positioning and centrosomal integrity, and
their mutant variants are associated with severe brain
malformation, including microcephaly (reviewed in
Faheem et al.128). Gene expression studies of embryonic
and fetal brain samples of ZIKV-infected mice and
ZIKV-infected NPCs revealed the downregulation of several MCPH genes, including those that code for centrosomal proteins (Table 2).116,117 Microcephalin, a
centrosomal protein (MCPH1) with a DNA repair functions, regulates G2/M checkpoint transition.129 RNA
depletion and mutation of MCHP1 resulted in premature
onset of chromosome condensation, and this may lead to
delayed mitosis.130,131 Reduced expression of MCPH1
increases the production of early born neurons, which
are located in deep layers (IV–VI), and reduces the lateborn neurons, which produce the thinner outer cortex
layer (II–III) (reviewed in Faheem et al.128).132,133 The
CASC5 protein attaches the kinetochore to microtubules
of the mitotic apparatus, ensuring correct segregation of
chromosomes.134 Mutated CASC5 resulted in mitotic
arrest and reduced brain volume.134–136 The deregulation
of CENPJ/CPAP, which is important for centrosome stability and duplication,137,138 resulted in the randomization of the cell’s division plane.139,140 CENPJ/CPAP
deletion resulted in the formation of multiple spindle
poles, apoptosis, and mitotic arrest.141 Loss of
CDK5RAP2 resulted in switching from symmetric proliferative divisions to asymmetric divisions of
NPCs.139,142 Cerebral organoids generated from human
cells harboring a truncated CDK5RAP2, while smaller
and containing fewer NPCs, also showed aberrant cell
polarity.143 These examples underscore the importance
of centrosomal proteins in neurogenesis; therefore, the
deregulation of their expression by viral infection can
produce severe brain malformation.
Potential ZIKV-induced downregulation of MCPH
genes may be related to viral microRNAs (miRNAs) or
short noncoding RNAs that target these said genes.
miRNAs are short (21–25 nucleotides) fragments of
RNAs that are partially complementary to mRNAs. By
hybridizing to the mRNA, an miRNA is able to downregulate or silent the expression of a specific gene posttranscriptionally. Computational modeling analyses
revealed a number of ZIKV miRNAs that can target
human MCPH genes.144,145 However, experimental evidence is needed to further elucidate the precise role(s) of
ZIKV in the deregulation of MCPH genes leading to
microcephaly. Such investigations may involve the use
of ZIKV-derived miRNAs to inhibit the expression of
specific MCPH gene and study the changes in embryonic,
fetal, and neonatal brains in animal models.
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Table 1. Molecular and Cytopathic Effects of Zika Virus Proteins.
Proteins
anaC
C
prM
M
E
NS2B

NS1

NS2A
NS3
NS4A

NS4B

NS5

Molecular and Cytopathic Effects
Cell elongation (fission yeast)
Cell cycle G1 accumulation (fission yeast)
Cell elongation (fission yeast)
Cellular hypotrophy (fission yeast)
Cell cycle G1 accumulation (fission yeast)
Cell elongation (fission yeast)
Cell cycle G2/M accumulation (fission yeast)
Cell elongation (fission yeast)
Cell cycle G2/M accumulation
Complexes with NS3 for proteosomal-directed JAK1 degradation (A549 cells)
N2B cooperates with NS1, NS4B and NS3 to block IFN-induced autophagic degradation
of NS2B-NS3 complex to enhance viral replication (A549 cells)
Cellular hypotrophy (fission yeast)
NS1 cooperates with NS4B and NS2B-NS3 to block IFN-induced autophagic-degradation
of NS2B-NS3 (A549 cells)
NS1 together with NS4B inhibit IFNb signaling by targeting TBK1 (TANK-binding kinase
1 level)
Reduces mouse radial glia proliferation and differentiation; degrades adhesion junction
proteins (mouse developing cortex)
Cooperate with NS1, NS4B and NS2 to block IFN-induced autophatic-associated
degradation of NS2B-NS3 complex to enhance viral replication (A549 cells)
Cellular hypotrophy (yeast fission)
Cell cycle G2/M accumulation (fission yeast)
Together with NS4B inhibit Akt-mTOR signaling and induce autophagy, limiting
neurogenesis (human fetal neural stem cells)
NS4B together with NS1 inhibit IFNb signaling by targeting TBK1 (TANK-binding kinase
1 level) (A549 cells)
Together with NS4A inhibit Akt-mTOR signaling and induce autophagy, limiting
neurogenesis (human fetal neural stem cells)
NS5 targets the IFN-regulated transcriptional activator STAT2 for proteosomal
degradation, inhibiting IFN signaling (293T cells).
NS5 enhances STAT1-STAT1 homodimers and their recruitment to IFN-g-stimulated
genes such as pro-inflammatory (JEG3 choriocarcinoma and SF268 glioblastoma cells)

Study
Li et al.124
Li
Li
Li
Li

et
et
et
et

al.124
al.124
al.124
al.124

Li et al.124
Wu et al.75
and Li et al.124
Wu et al.75
Li et al.124
Wu et al.75
Wu et al.75
Yoon et al.125
Wu et al.75
Li et al.124
Li et al.124
Li et al.124
Wu et al.75
Liang et al.126
Grant et al.71
Chaudhary et al.127

Abbreviations: anaC, membrane-anchored capsid; C, capsid protein; E, envelope protein; IFN, interferon; M, membrane protein; prM, premembrane protein.

Disruption of Cell Cycle Progression of
Neuronal Precursors
During forebrain development, NPCs proliferate, differentiate in diverse neuronal cell fates, and migrate to their
final position in the cortical plate, where they mature into
adult neurons. The temporal and spatial precisions with
which these processes occur during telencephalic development are important for higher order functions including
language, emotion, and cognition. Therefore, eradication
of NPCs during telencephalic development can lead to
severe neurodevelopmental problems including primary
congenital microcephaly.166–168 As indicated, ZIKV-

induced upregulation of TLR3 in NPCs is associated
with the deregulation of genes involved in neurogenesis,
including those that regulate cell cycle progression.110
Following ZIKV infection of NPCs, G1 phase regulatory
proteins including cyclin D1 (CCND1), cyclin-dependent
kinase (CDK4), and E2F1, E2F3, and JUN transcription
factors were downregulated, whereas cyclin-dependent
kinase inhibitor 2A (CDKN2A/p16) and a CCND1
inhibitor were upregulated.119 These alterations may represent an underlying mechanism that resulted in
decreased M phase NPC population116 and the accumulation of sub-G1 phase cycle in ZIKV-infected neurospheres grown from NPCs.111 The specific roles of
ZIKV proteins in cell cycle delay have been demonstrated
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Table 2. Microcephaly Genes That Are Potentially Deregulated in ZIKV-Associated Fetal and Pediatric Neuropathologies.
Gene Symbol

Gene Name

Protein Function

CDK5RAP2

CDK5 regulatory subunitassociated protein 2

Centrosomal protein localizes to
centrosome during mitosis142

MCPH1

Microcephalin

Chromosomal condensation,
G2/M checkpoint regulator129

CASC5

Cancer susceptibility
candidate 5

WDR62

WD repeat-containing
protein 62

Attaches chromosome kinetochore to microtubule of
mitotic apparatus, chromosome segregation134
Localizes to the nucleus and
centrosome, regulate mitosis
progression in NPCs149,150

ASPM

Abnormal spindle-like
microcephaly-associated protein

CENPJ/CPAP

Centromere protein J

STIL

SCL/TAL1-interrupting
locus

CEP135

Centrosome protein of
135 kDa
Zinc finger protein 335

Maintains structural organization
of the centrosome159
Controls neural progenitor selfrenewal, neurogenesis, and
neuronal differentiation163

PHC1

Polyhomeotic-like protein
1

Chromatin remodeling/cell cycle
regulation164

CDK6

Cyclin-dependent kinase 6

Associates with centrosome
during mitosis and regulates
centrosome number, organizes microtubules165

ZNF335

Regulates orientation of mitotic
spindle in NPCs, symmetric
divisions in neuroepithelial
cells154,155
Important for centrosome
integrity and spindle
morphology139,140
Regulates mitotic spindle checkpoint and apoptosis158

Putative Cellular Effects/Defects on Brain
Development
CDK5RAP2 mutation reduces the progenitor
pool, thereby decreasing the number of
neurons, reduces cell survival146–148
Reduced MCPH1 enhances the production of
early born neurons, which comprise deep
layers (IV–VI), and reduces the late-born
neurons, which produce the thinner outer
cortex layer (II–III)132,133
Defects in CASC5 may result in decreased
volume of the human brain134–136

Neurocortical development, proliferation and
migration of neuronal precursors, WDR62
mutations affect its role in proliferating and
migrating NPCs, delay mitotic progression, and
causes severe brain malformations150–153
ASPM mutations alter orientation of mitotic
spindle, reducing the size of the brain156,157

CENJP deletion causes an increased incidence of
multiple spindle poles, apoptosis, and mitosis
arrest141
STIL mutation is lethal to zebrafish embryos, and
STIL knockout mice (Sil / ) exhibit numerous
developmental abnormalities/decreased size/
defective midline neural tube158–160
CEP135 knockdown resulted in restricted growth
rate/disorganized microtubules159,161,162
Mutated ZNF335 gene causes degeneration of
neurons, knockdown of ZNF335 caused a
small brain size with an absent cortex/
disrupted proliferation and differentiation of
neuronal cells163
Mutated PHC1-associated chromatin remodeling
is suspected in pathogenesis of primary
mycophagy164
CDK6 mutation affects apical neuronal precursor
cells proliferation/reduces progenitor pool/
decreases neuronal production/primary
microcephaly165

Abbreviation: NPCs, neural progenitor cells.

in fission yeast.124 The expression of ZIKV prM protein
resulted in cell cycle G1 accumulation, whereas the
expression of proteins encoded by anaC, M, E, and
NS4A lead to cell cycle G2/M accumulation.124 Of indirect relevance, Li et al.116 showed decreased M phase
NPCs in ZIKV-infected neurospheres, whereas Li
et al.124 indicated the accumulation of G2/M phase

accumulation cells. This discrepancy may be explained
on the basis of differences in expression systems used.

Neuronal Cell Death
As indicated, ZIKV can induce cell death by apoptosis
and by autophagy.14,117,119 ZIKV-induced apoptosis is
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evident by abnormal morphological changes in infected
neurons (as described).1,12 In addition, ZIKV infections
resulted in increased caspase-3 (CASP3) activities in
in vitro and in vivo models; in proliferative, immature
(eg, NPCs) and mature neurons; and in human neuroepithelial stem cells.14,15,116,119–121 The activation of CASP3
may be a result of ZIKV suppression of cellular immune
response. Cells of the anterior subventricular zone (SVZ)
of the forebrain and subgranular zone of the hippocampal dentate gyrus of ZIKV-infected mice, deficient in IFN
response factor, showed elevated CASP3 activities.169
Moreover, ZIKV induced cell death by autophagy in
hNPCs generated from induced PSCs, neurospheres
raised from NPCs, and in vivo studies using SJL
mice.14,116,117,119 It is presumed that after infecting the
NPCs of the fetal brain, ZIKV nonstructural proteins
NS4A and NS4B suppressed the P13K-Akt-mTOR pathway, resulting in autophagy and inhibiting neurogenesis
(Table 2).126,170,171 Although apoptosis and autophagy
can be independent mechanisms of cell death, ZIKV
infection can affect the expression of genes involved in
both processes. Studies showed that ZIKV neurotropism
resulted in the upregulation of Bmf, DAPK3, Irgm1,
PKD Bcl2, Htt, CASP3, Caspa, MIL1, ATG2, ATG3,
ATG9, Abl1, ATF4, ULK1, AMBRA1, IRE1, and
TNFRSF1 and the suppression of CASP2, CASP6,
GADD45a, VPS34, Fasl, ATG12, Bcl2l11, Dffa, and
ATF6.14,116,117,119 Finally, ZIKV-induced translocation
of the centrosomal protein phosphor-TBK1 to the mitochondria of human neuroepithelial stem cells and radial
glial (RG) cells, lead to cell death, among other cellular
effects.121 Examination of postmortem forebrain of
ZIKV-associated microcephaly revealed massive death
of cells that correspond to NPCs.121 Some of these
events involved in ZIKV-associated microcephaly
mirror those linked to mutational and heredity microcephaly. Mice and humans with mutations in centrosomal genes exhibit deficits including supernumerary
centrosomes and failed cytokinesis, resulting in severely
defective neurogenesis, extensive apoptosis in the proliferative zones, and microcephaly.172–175
ZIKV-induced inflammation may also drive the death
of NPCs, via paracrine mode. During early development,
cranial neural crest cells (CNCCs) that form the cranial
bones exert paracrine effects on the developing brain. An
in vitro study showed that ZIKV-infected CNCCs,
although resistant to apoptosis, secrete significant levels
of cytokines that resulted death NPCs.176

Inhibition of Neuronal Migration
Defects in neuronal migration have been linked to congenital microcephaly.177 Studies indicated that ZIKV
infection is associated with the inhibition of neural
migration, and perhaps leading to ZIKV-associated
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microcephaly. As indicated, ZIKV infects RGs,121
which are also important for the development of the
CNS.178 RGs are housed deep within the embryonic
and fetal brain from where they project radial fibers to
the pia surface of the cortex.179 The radial fibers form
tissue scaffold that guide migrating newborn neurons to
their correct positions in the cortical plate. RGs also act
as neural stem cell pools, with the potential to differentiate into diverse neuronal and glial cell types, including
neurons, oligodentrocytes, and astrocytes. Therefore,
eradication of RGs (eg, by viral infections) can lead to
severe developmental defects and limited cortical formation. ZIKV particles have been detected in the RGs of
infected mice brains.116 ZIKV infection of RGs might be
facilitated by the expression of the putative ZIKV candidate receptor AXL in the cortex, with very strong expression bordering the lateral ventricle and the outer SVZ,180
a region where RGs are known to reside in humans.181
A recent study showed that ZIKV NS2A protein reduced
proliferation of RGs and also degrade adherent junction
(AJ) proteins in mouse cerebral cortex and human forebrain organoids.125 ZIKV-associated loss of AJ can result
in aberrant glial scaffold and misdirected neurons.
At the molecular level, ZIKV infections resulted in the
downregulation of genes that code for proteins involved
in neuronal migration (as well as neuronal maturation
and differentiation).116 Among these genes are those
that code for (Jun, JunB, Egr2, and KLF4) transcription
factors116 that regulate the expression of gap junction
proteins, connexins—Cx43 and Cx26.182–185 Connexins
have been implicated in neuronal migration.183,186 Cx43
and Cx26 proteins accumulate at the point where migrating neurons contact RG fibers.186 Loss of Cx43 expression resulted in reduced neuronal migration, thereby
disrupting brain development,187–189 a feature consistent
with migration defects.
Inhibition of neuronal migration may be related to
ZIKV-associated deregulation of the MCPH protein,
WDR62. WDR62 protein is expressed by NPCs as well
as by postmitotic neurons of the developing brain
and localizes to the spindle poles of dividing cells
(Table 2).149,150 Mutations in the WDR62 protein or
depletion of its mRNA have been linked to defects in
neuronal migration.151,153
Although much of the forgoing discussion indicated
NPCs are principal ZIKV targets, the heterogenous
gene expression and the lack of normal 3D brain architecture generated from NPCs raised from iPSCs or
embryonic stem cells to model ZIKV brain infection
prompted a search for other ZIKV neurocellular targets.
A recent study using fetal brain slices obtained from the
second trimester gestational period suggested that intermediate progenitor cells (IPCs) and committed postmitotic cells are the main neurocellular targets of ZIKV in the
fetal brain.190 Although IPCs are located mainly in the
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SVZ, they undergo limited mitotic division191–194 and
their eradication can still lead to deficits in cortical formation. However, the study by Lin et al.190 suffers from a
lack of first trimester brain samples, a time when the fetal
brain is most susceptible to ZIKV infection. Therefore, it
is possible that first trimester NPCs are principal cellular
targets of ZIKV insults.
In summary, cell death, neuronal migration defects,
and misdirected and reduced proliferation associated
with ZIKV infection of NPCs, can lead to the formation
of a thinner cortex of the developing forebrain (Figure 3).

ZIKV-Associated Congenital
Ocular Anomalies
A number of clinical studies have reported ocular anomalies, specifically in the retina and choroid, of infants with
congenital ZIKV infection.195–199 ZIKV invasion of ophthalmic tissues resulted in adverse illnesses, which include
optic neutitis, chorioretinal atrophy, circumscribed
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pigment, iris colobomas, and lens subluxation, and blindness in neonates, and conjunctivitis and uveitis in
adults,56,200 have been reported. In addition, AXL
expression has been observed in the outer margin of the
neural retina and in cells of the ciliary marginal zone
adjacent to neural retina,180,201 suggesting a possible
underlying mechanism for macular atrophy (leading to
blindness) in babies born to ZIKV-infected mothers. In
IFNRA1 knockout (IFNRAI / ) mice, ZIKV infection
was found in the optic nerve, retina, iris, and cornea, and
also triggered panuveittis, conjunctivitis, and neuroretinitis.56 In addition, retinal neurons appeared to be targeted
by ZIKV and this was associated with infections in the
lateral geniculate, suprachiasmatic nuclei, and superior
colliculus,202 indicating a potential for the virus to
infect cells along the visual pathway. This selective infection may be due to axonal transport of viral particles.202
ZIKV can also disturb the retinal vasculature. ZIKV
targets retinal endothelial cells, retinal pericytes, and retinal pigmented epithelial cells of the blood-retinal barrier,

Figure 3. During the formation of the neural cortex, neural progenitors are generated in the SVZ from where they migrate along radial
glial fibers to the pia surface. The cortex develops in an ‘‘inside-out’’ manner. First-born neurons differentiate and occupy layers VI and V,
and those produced later, will reside in layers IV, III, II, and I. In this manner, layer I is the last to form. It is presumed that ZIKV-induced
depletion of NPCs resulted in a thinner neural cortex-associated microcephaly.
SVZ, subventricular zone; ZIKV, Zika virus.
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where its replicates productively and stimulates
the expression of the inflammatory cytokine,
RANTES,203,204 potentially disrupting the permeability
of the retinal vasculature, and resulting in chorioretinal
atrophy.203 These data, taken together, suggest that
ZIKV may produce eye diseases, leading to blindness in
newborns arising from infected pregnancies.

Conclusion
Accelerated laboratory research has now confirmed
that ZIKV is a potential teratogenic agent, associated
with increased incidences of primary/congenital and
progressive microcephaly, among other associated neurodevelopmental disorders. The virus targets the neural
stem cell pools, deregulating genes involved in cell
death, proliferation, differentiation, and migration.
ZIKV-induced disruption of neurogenesis may lead to
the formation of thinner forebrain cortex. To inflict its
catastrophic effects on brain development, ZIKV must
first traverse the placental barrier. In vitro and
in vivo evidence indicate that ZIKV infection compromises placental integrity, more so during the first trimester.
In addition, ZIKV-induced placental-derived inflammatory cytokines may also contribute to the demise of
NPCs, in utero.
A major challenge in ZIKV research is to determine
the precise mechanism(s) of cellular invasion. A good
measure of studies identified several putative ZIKV
entry receptors. AXL expression has been reported for
both placenta and fetal brain tissues, and this correlates
well with ZIKV neuropathological effects. However,
some studies showed that ZIKV infection occurs in the
absence of AXL expression, indicating that other unidentified receptors might mediate viral infections. Receptorindependent mechanisms including exosomes and ECVs
and TNTs for viral dissemination are also possible. The
use of exosomes and TNTs for spreading viral infection
allows viruses to escape immune detection and eradication. Whether ZIKV tropism uses a receptor-independent
mechanism remains a question for further debate
and research. However, it is hopeful that current and
future research endeavors will help to elucidate the precise mechanism(s) of ZIKV neuropathologies, with the
hope of providing effective treatment and developing
measures to limit the dissemination of the virus in
infected hosts.
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